A group of researchers led by Leif Schroeder from the Leibniz-Forschungsinstitut fuer Molekulare Pharmakologie (FMP) have found a way to detect metastases in certain types of cancer in the brain at an ...

A new magnetic resonance imaging (MRI) contrast agent being tested by researchers at Case Western Reserve University not only pinpoints breast cancers at early stages but differentiates between ...

An "Original Research" article published in ARRS' American Journal of Roentgenology (AJR) concluded that the accuracy of breast cancer diagnosis via diffusion-tensor imaging (DTI) was equivalent both ...

MRI contrast agents, which are typically gadolinium-based, are used to enhance visualization of abnormal structures or lesions and to aid differentiation between healthy and pathological tissue. This ...

Scientists at the Institute of Chemistry have developed a new type of contrast agent for magnetic resonance imaging (MRI)—bovine serum albumin nanoparticles doped with manganese (II) ions. The results ...

Magnetic resonance imaging (MRI) visualizes internal body structures, often with the help of contrast agents to enhance sensitivity. Scientists have now developed a bimodal contrast agent suited for ...

The top causes of death worldwide, ischemic heart diseases and stroke, together with another major source of illness, that is cancer, require proper imaging of blood vessels. A team formed by the ...

Experiments in dogs, rabbits and monkeys show the efficacy and biocompatibility of a new MRI/MRA contrast agent in detecting stroke. This T1 MRI contrast agent based on ultrasmall iron oxide ...